Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VOSEVI - Health Canada Drug Approval Details

Approvals/Health Canada/VOSEVI

Authorized

STANDARD

VOSEVI

GILEAD SCIENCES CANADA INC🇨🇦 Health Canada

Approval Date: Apr 6, 2026
Approval ID: 72ff1d03cb3c8548
Company: GILEAD SCIENCES CANADA INC
Type: Standard

Approval Details

Approval Id: 72ff1d03cb3c8548
Drug Approval Canada Name: VOSEVI
Product Name: VOSEVI
Status: Marketed
Status Date: 2017-09-18
Original Market Date: 2017-09-18
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: PRESCRIPTION
Ahfs: 08:18.40.16
Atc Original: J05AP56 SOFOSBUVIR, VELPATASVIR AND VOXILAPREVIR
Aig Number: 0359370001
Company Name: GILEAD SCIENCES CANADA INC
Company Address: 400 6925 Century Avenue Mississauga Ontario Canada L5N 7K2

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Apr 6, 2026

Approval ID

72ff1d03cb3c8548

Type

Standard

Back to Health Canada Approvals